Kymera Therapeutics, Inc. (KYMR) vs TG Therapeutics, Inc. (TGTX)
A side-by-side comparison of Kymera Therapeutics, Inc. and TG Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KYMR
Kymera Therapeutics, Inc.
$105.66HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
TGTX
TG Therapeutics, Inc.
$52.49HealthcareDelayed quote: Oct 6, 2026, 2:50 PM EDT
Total return — KYMR vs TGTX
growth of $100 · dividends reinvested · last 6yKYMR +230.3% (+22.0%/yr)TGTX +128.7% (+14.8%/yr)KYMR compounded faster over this window
KYMR TGTX
KYMR vs TGTX: by the numbers
- •KYMR is the larger company ($8.69B vs $8.04B market cap).
- •TGTX is profitable (55.22% net margin) while KYMR runs a net loss (-285.41%).
- •TGTX grew revenue faster over the past five years (219.22% vs 10.22% CAGR).
Metrics side by side
Valuation
| Metric | KYMR | TGTX |
|---|---|---|
| P/E ratio | N/A | 19.16 |
| Forward P/E | N/A | 53.93 |
| P/S ratio | 82.78 | 10.05 |
| P/B ratio | 5.76 | 13.30 |
| EV / EBITDA | N/A | 60.80 |
| FCF yield | N/A | 0.22% |
Profitability
| Metric | KYMR | TGTX |
|---|---|---|
| Gross margin | 101.98% | 82.36% |
| Operating margin | -891.33% | 17.05% |
| Net margin | -285.41% | 55.22% |
| ROE | -19.85% | 73.08% |
| ROIC | -22.30% | 9.94% |
Growth (annualized)
| Metric | KYMR | TGTX |
|---|---|---|
| Revenue CAGR (5Y) | 10.22% | 219.22% |
| Total return CAGR (5Y) | 12.31% | 10.75% |
Frequently asked
- Which has grown faster, KYMR or TGTX?
- Over the past five years, TGTX grew revenue faster — KYMR at a 10.22% CAGR versus TGTX at 219.22%.
- Is KYMR or TGTX more profitable?
- TGTX runs the higher net margin — KYMR at -285.41% versus TGTX at 55.22%.
- How have KYMR and TGTX total returns compared?
- Over the past 5 years, KYMR delivered 12.31% and TGTX delivered 10.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
TG Therapeutics P/E ratioKymera Therapeutics ROETG Therapeutics ROEKymera Therapeutics operating marginTG Therapeutics operating marginKymera Therapeutics revenue growthTG Therapeutics revenue growthKymera Therapeutics free cash flowTG Therapeutics free cash flow
Kymera Therapeutics & TG Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.